APRIL 20246Managing EditorAlex D'souzaVisualizerChris LynnMichael WayneAPRIL - 15 - 2024, volume 07 - Issue 03 (ISSN 2691-4093) Published by ValleyMedia, Inc. Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comTo subscribe to Medical Tech OutlookVisit www.medicaltechoutlook.com Copyright © 2024 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comThe field of cardiovascular devices and solutions is experiencing a surge of innovation, with minimally invasive techniques, AI-driven solutions and the rise of digital health at the forefront of these advancements. Minimally invasive approaches are becoming increasingly sophisticated, driven by advancements in both materials science and imaging technology. New devices are designed to be implanted with greater precision using smaller incisions, resulting in less trauma and faster recovery times for patients. This shift towards minimally invasive procedures is reshaping the standard of care in cardiovascular medicine.The rise of digital health and remote monitoring technologies is transforming the way cardiovascular conditions are managed. Wearable sensors and connected implantable devices can wirelessly collect and transmit health data to healthcare providers. This allows for early intervention, reduces the need for frequent in-person visits, and empowers patients to take a more active role in their health. Remote monitoring offers a continuous lens into the chronic management of cardiovascular diseases, fostering a more patient-centric approach and the potential for enhanced outcomes.Driven by these trends, the cardiovascular device market is estimated to reach $75.04 billion by 2029, growing at a CAGR of 4.97 percent. This edition of MedTech Outlook examines the latest developments in the cardiovascular device market.It features a thought leadership article by Fadi Matar, Interim Chief of Cardiology of University of South Florida, discussing the evolving landscape of cardiovascular therapies, emphasizing the importance of timely identification of tricuspid regurgitation in patients and referral to specialized centers for access to advanced technologies and therapeutic interventions.In this edition of MedTech Outlook, we also bring you the story of Corvion, a medical device company pioneering a highly efficient and fully implanted left ventricular assist device (LVAD) paired with wireless charging technology, aiming to revolutionize mechanical circulatory support and enhance patient outcomes in heart failure treatment.In this edition featuring the Top Cardiovascular Devices Providers 2024, we hope you find the right partner to meet your organization's needs.Let us know your thoughts!Innovations Shaping Cardiovascular CareEDITORIALEditorial StaffJoe PhilipLaura PintoJoshua ParkerMerlin WatsonSarah FernandesGina ClumskyYenny TurnerTiffany Hayworth
< Page 5 | Page 7 >